India plans 30% trade-margin cap on non-scheduled cancer drugs
FROM THE WIRE · LIVEMINT.COM
The proposed cap could cut retail prices by up to 70%, with the government moving ahead of a broader crackdown on steep mark-ups in cancer medicines.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishRegulatory margin cap on cancer drugs could cut retail prices up to 70%, pressuring pharmaceutical industry margins.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Indian government planning 30% trade-margin cap on non-scheduled cancer drugs.
- 02Proposed cap could cut retail prices by up to 70% according to estimates.
- 03Measure is part of broader government crackdown on steep mark-ups in cancer medicines.